West Pharmaceutical Services · Total Non-Current Assets

WST Total Non-Current Assets

Latest reported$2.27Bperiod endingJun 30, 2026

WST Quarterly Non-Current Assets ($122.50M → $2.27B)

Quarterly total non-current assets

High-resolution chart · PNG

WST total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Total Non-Current Assets — Quarterly (USD)
Period ending	Total Non-Current Assets (USD)
Jun 30, 2026	2,268,900,000
Mar 31, 2026	2,283,000,000
Dec 31, 2025	2,291,900,000
Sep 30, 2025	2,282,500,000
Jun 30, 2025	2,271,900,000
Mar 31, 2025	2,160,700,000
Dec 31, 2024	2,105,400,000
Sep 30, 2024	2,124,500,000
Jun 30, 2024	2,006,400,000
Mar 31, 2024	1,909,400,000
Dec 31, 2023	1,893,100,000
Sep 30, 2023	1,782,400,000
Jun 30, 2023	1,795,400,000
Mar 31, 2023	1,786,400,000
Dec 31, 2022	1,697,300,000
Sep 30, 2022	1,583,200,000
Jun 30, 2022	1,590,600,000
Mar 31, 2022	1,604,200,000
Dec 31, 2021	1,571,800,000
Sep 30, 2021	1,544,300,000
Jun 30, 2021	1,456,500,000
Mar 31, 2021	1,412,700,000
Dec 31, 2020	1,420,100,000
Sep 30, 2020	1,344,500,000
Jun 30, 2020	1,281,700,000
Mar 31, 2020	1,269,000,000
Dec 31, 2019	1,282,700,000
Sep 30, 2019	1,169,900,000
Jun 30, 2019	1,178,900,000
Mar 31, 2019	1,168,600,000
Dec 31, 2018	1,084,600,000
Sep 30, 2018	1,096,000,000
Jun 30, 2018	1,106,800,000
Mar 31, 2018	1,126,100,000
Dec 31, 2017	1,119,300,000
Sep 30, 2017	1,153,500,000
Jun 30, 2017	1,125,200,000
Mar 31, 2017	1,080,900,000
Dec 31, 2016	1,074,800,000
Sep 30, 2016	1,077,200,000
Jun 30, 2016	1,045,900,000
Mar 31, 2016	1,037,500,000
Dec 31, 2015	1,021,400,000
Sep 30, 2015	985,600,000
Jun 30, 2015	983,800,000
Mar 31, 2015	970,900,000
Dec 31, 2014	1,011,600,000
Sep 30, 2014	993,800,000
Jun 30, 2014	1,019,300,000
Mar 31, 2014	1,021,600,000
Dec 31, 2013	1,020,900,000
Sep 30, 2013	1,021,000,000
Jun 30, 2013	999,400,000
Mar 31, 2013	987,400,000
Dec 31, 2012	1,006,700,000
Sep 30, 2012	970,100,000
Jun 30, 2012	945,800,000
Mar 31, 2012	954,500,000
Dec 31, 2011	927,100,000
Sep 30, 2011	894,800,000
Jun 30, 2011	904,900,000
Mar 31, 2011	885,000,000
Dec 31, 2010	857,700,000
Sep 30, 2010	858,400,000
Jun 30, 2010	818,200,000
Mar 31, 2010	848,700,000
Dec 31, 2009	873,800,000
Sep 30, 2009	864,800,000
Jun 30, 2009	821,300,000
Mar 31, 2009	785,300,000
Dec 31, 2008	802,500,000
Sep 30, 2008	799,500,000
Aug 5, 2008	810,000,000
Mar 31, 2008	791,000,000
Dec 31, 2007	773,300,000
Sep 30, 2007	718,700,000
Jun 30, 2007	690,400,000
Mar 31, 2007	674,000,000
Dec 31, 2006	636,500,000
Sep 30, 2006	609,200,000
Jun 30, 2006	600,400,000
Mar 31, 2006	588,300,000
Dec 31, 2005	586,400,000
Sep 30, 2005	581,700,000
Jun 30, 2005	542,100,000
Mar 31, 2005	427,000,000
Dec 31, 2004	432,200,000
Sep 30, 2004	417,300,000
Jun 30, 2004	409,800,000
Mar 31, 2004	410,000,000
Dec 31, 2003	406,900,000
Sep 30, 2003	382,200,000
Jun 30, 2003	378,100,000
Mar 31, 2003	369,400,000
Dec 31, 2002	375,500,000
Sep 30, 2002	361,700,000
Jun 30, 2002	371,600,000
Mar 31, 2002	354,300,000
Dec 31, 2001	352,800,000
Sep 30, 2001	393,300,000